Analyst Consensus ?
ConsensusHold28 ratings
Bullish1242.9%
Neutral1657.1%
Bearish00.0%
FN2 Earnings Intelligence
Invesco Ltd. analyst ratings
Invesco Ltd. (IVZ) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$29.02Current
$17Low
$28.95Average
$36High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 28, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 22, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Oct 13, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 12, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 9, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Oct 9, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 29, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Apr 29, 2026 |
| Argus Research | Buy | Buy | Maintain | Jan 28, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | Dec 17, 2025 |
| B of A Securities | Neutral | Neutral | Maintain | Oct 2, 2025 |
| Citigroup | Neutral | Neutral | Maintain | Sep 29, 2025 |
| Wells Fargo | Equal Weight | Underweight | Upgrade | Jul 11, 2025 |
| UBS | Neutral | Neutral | Maintain | Feb 3, 2025 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jan 29, 2025 |
| Credit Suisse | Neutral | Underperform | Upgrade | Mar 29, 2023 |
| Jefferies | Hold | Buy | Downgrade | Jun 7, 2019 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | Jul 13, 2018 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| Bank of America | Neutral | Buy | Downgrade | Jan 8, 2018 |
| Keefe, Bruyette& Woods | Perform | Outperform | Downgrade | Dec 12, 2016 |
| Susquehanna | Positive | Positive | Maintain | Sep 3, 2015 |
| PiperJaffray | Overweight | Overweight | Maintain | Jun 3, 2015 |
| Sterne Agee | Buy | Neutral | Upgrade | Jan 7, 2015 |
| Evercore Partners | Equal Weight | Equal Weight | Maintain | Jul 10, 2013 |
| Nomura | Buy | Buy | Maintain | May 1, 2013 |
| Stifel Nicolaus | Buy | Buy | Maintain | Feb 1, 2013 |
| Stifel | Buy | Buy | Maintain | Feb 1, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $29.02. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $36 | $28.8 | +24.1% | Oct 13, 2026 |
| RBC Capital | Analyst unavailable | $36 | $29.68 | +24.1% | Oct 9, 2026 |
| Evercore ISI | Analyst unavailable | $34 | $29.69 | +17.2% | Oct 9, 2026 |
| UBS | Analyst unavailable | $41 | $30.38 | +41.3% | Oct 6, 2026 |
| Morgan Stanley | Michael Cyprys | $31 | $30.68 | +6.8% | Sep 25, 2026 |
| RBC Capital | Analyst unavailable | $39 | $32.02 | +34.4% | Aug 13, 2026 |
| Evercore ISI | Analyst unavailable | $35 | $32.05 | +20.6% | Aug 10, 2026 |
| Barclays | Analyst unavailable | $32 | $29.43 | +10.3% | Jul 29, 2026 |
| Barclays | Analyst unavailable | $31 | $28.4 | +6.8% | Jul 14, 2026 |
| Evercore ISI | Analyst unavailable | $32 | $29.08 | +10.3% | Jul 10, 2026 |
| Evercore ISI | Analyst unavailable | $31 | $27.79 | +6.8% | Jun 8, 2026 |
| Goldman Sachs | Alexander Blostein | $30 | $25.88 | +3.4% | Apr 29, 2026 |
| Barclays | Analyst unavailable | $26 | $25.88 | -10.4% | Apr 29, 2026 |
| RBC Capital | Kenneth Lee | $31 | $24.95 | +6.8% | Apr 21, 2026 |
| Evercore ISI | Analyst unavailable | $27 | $23.63 | -7.0% | Apr 10, 2026 |
| BMO Capital | Analyst unavailable | $28 | $23.63 | -3.5% | Apr 10, 2026 |
| RBC Capital | Kenneth Lee | $33 | $27.76 | +13.7% | Jan 28, 2026 |
| Cowen & Co. | Analyst unavailable | $34.5 | $27.28 | +18.9% | Jan 28, 2026 |
| Argus Research | Stephen Biggar | $31 | $27.26 | +6.8% | Jan 28, 2026 |
| Goldman Sachs | Analyst unavailable | $29.5 | $27.16 | +1.7% | Jan 28, 2026 |
| Barclays | Analyst unavailable | $29 | $27.16 | -0.1% | Jan 28, 2026 |
| Morgan Stanley | Analyst unavailable | $29 | $28.4 | -0.1% | Jan 26, 2026 |
| RBC Capital | Kenneth Lee | $35 | $28.95 | +20.6% | Jan 21, 2026 |
| Goldman Sachs | Alexander Blostein | $28.75 | $28.25 | -0.9% | Jan 15, 2026 |
| Barclays | Benjamin Budish | $30 | $28.25 | +3.4% | Jan 15, 2026 |
| Goldman Sachs | Alexander Blostein | $28.25 | $28.16 | -2.7% | Jan 6, 2026 |
| Morgan Stanley | Analyst unavailable | $28 | $26.82 | -3.5% | Dec 17, 2025 |
| Deutsche Bank | Analyst unavailable | $31 | $26.03 | +6.8% | Dec 17, 2025 |
| Barclays | Benjamin Budish | $28 | $26.99 | -3.5% | Dec 12, 2025 |
| BMO Capital | Analyst unavailable | $30 | $26.54 | +3.4% | Dec 10, 2025 |
| Goldman Sachs | Analyst unavailable | $25.5 | $23.81 | -12.1% | Nov 25, 2025 |
| Fundamental Research | Analyst unavailable | $27 | $23.66 | -7.0% | Oct 31, 2025 |
| RBC Capital | Kenneth Lee | $25 | $24.02 | -13.9% | Oct 30, 2025 |
| Goldman Sachs | Analyst unavailable | $26.5 | $24.35 | -8.7% | Oct 29, 2025 |
| Barclays | Analyst unavailable | $24 | $22.84 | -17.3% | Oct 21, 2025 |
| Morgan Stanley | Analyst unavailable | $26 | $23.98 | -10.4% | Oct 6, 2025 |
| Evercore ISI | Glenn Schorr | $24 | $21.99 | -17.3% | Sep 5, 2025 |
| Wells Fargo | Michael Brown | $18 | $17.43 | -38.0% | Jul 11, 2025 |
| Barclays | Benjamin Budish | $19 | $18.04 | -34.5% | Oct 23, 2024 |
| Wells Fargo | Michael Brown | $16 | $15.8 | -44.9% | Sep 11, 2024 |
| RBC Capital | Kenneth Lee | $16 | $14.52 | -44.9% | Apr 25, 2024 |
| Deutsche Bank | Brian Bedell | $17 | $16.53 | -41.4% | Apr 5, 2024 |
| Morgan Stanley | Analyst unavailable | $23 | $18.96 | -20.7% | Apr 27, 2022 |
| Deutsche Bank | Brian Bedell | $24 | $19.03 | -17.3% | Apr 27, 2022 |
| Morgan Stanley | Analyst unavailable | $25 | $20.39 | -13.9% | Apr 25, 2022 |
| RBC Capital | Kenneth Lee | $23 | $21.41 | -20.7% | Jan 24, 2022 |
| Barclays | Jeremy Campbell | $25 | $26.29 | -13.9% | Apr 30, 2021 |
| Argus Research | Stephen Biggar | $33 | $26.51 | +13.7% | Apr 28, 2021 |
| Wells Fargo | Christopher Harris | $25 | $25.23 | -13.9% | Apr 13, 2021 |
Track every rating change on IVZ the moment it posts. Free to start.
Start freeGet the IVZ recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.